We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Thermo Fisher Scientific - Direct Effect Media

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

State-of-the-Art Syringe Infusion System Answers Worldwide Need for Portable, Non-Electric, Versatile Infusion Pump

By HospiMedica International staff writers
Posted on 17 Mar 2022
Print article
Image: Insignis Infusion Pump operates independent of battery power or electricity (Photo courtesy of Innovative Health Sciences, LLC)
Image: Insignis Infusion Pump operates independent of battery power or electricity (Photo courtesy of Innovative Health Sciences, LLC)

A state-of-the-art syringe infusion system for intravenous administration answers the worldwide need for a portable, non-electric, versatile, cost-effective, and intuitive infusion pump to accurately deliver medications from KVO up to 250ml/hr with a direct reading selectable rate flow controller. The fully mechanical, non-electric infusion pump operates independent of battery or electricity, allowing it to be stockpiled, transported, and stored for emergency situations in locations where resources may be scarce or absent.

Innovative Health Sciences, LLC (IHS, Chester, NY, USA) is offering the Insignis syringe infusion system which is the first combination of intravenous and subcutaneous non-electric infusion pump created for use with a selectable rate flow controller, the intravenous controller and OneSett subcutaneous administration set. Unlike other infusers, the Insignis system enables the rate to be titrated and adjusted easily and quickly without drip chambers or inaccurate rate controllers. For subcutaneous applications, the OneSett consists of a selectable rate flow controller attached directly to a subcutaneous needle set (1-4 leg configuration offering), which enables the user to select the flow rate (from 10ml-60ml) with the turn of a dial. The flow rate indicated on the dial is delivered to each needle site - no calculation is required.

IHS has received CE Certification for the Insignis syringe infusion system, enabling its sales in the European Union. The Insignis syringe pump is much less costly, offered at EURO 139, and when considering the cost of the separate pieces of the ancillary supplies (needle sets, flow control tubings, and flow controller), the OneSett is also lower cost per infusion - even before considering the savings incurred from fewer stocking parts. The Insignis syringe infusion system addresses 80-90% of the needs of infusion therapy, providing simplicity, safety, versatility, and usability. In emergency situations, it may be used for hypodermoclysis (subcutaneous rehydration when intravenous access is not feasible), antibiotics or antivirals, and fluid volume assist medications. It can also support intermittent, “pause” dosing, ideal for lengthy low-volume hospital infusions.

“The IHS system represents a paradigm shift in simplicity, excellence, cost effectiveness, usability and patient-centered design,” said Andrew Sealfon, IHS founder, chairman, and chief technology officer.

Related Links:
Innovative Health Sciences, LLC 


Print article

Channels

Surgical Techniques

view channel
Image: A minimally invasive diagnostic biomarker strategy has proven successful in detecting early esophageal cancer (Photo courtesy of Pexels)

Minimally Invasive Device Combined With Molecular Biomarkers Detects Early Esophageal Cancer

Esophageal cancer remains the sixth-most common cause of cancer death worldwide, claiming the lives of more than half a million people annually. Esophageal squamous cell carcinoma (ESCC) comprises 80%... Read more

Patient Care

view channel
Image: Future wearable health tech could measure gases released from skin (Photo courtesy of Pexels)

Wearable Health Tech Could Measure Gases Released From Skin to Monitor Metabolic Diseases

Most research on measuring human biomarkers, which are measures of a body’s health, rely on electrical signals to sense the chemicals excreted in sweat. But sensors that rely on perspiration often require... Read more

Health IT

view channel
Image: AI can reveal a patient`s heart health (Photo courtesy of Mayo Clinic)

AI Trained for Specific Vocal Biomarkers Could Accurately Predict Coronary Artery Disease

Earlier studies have examined the use of voice analysis for identifying voice markers associated with coronary artery disease (CAD) and heart failure. Other research groups have explored the use of similar... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.